14,450,868 Shares of Common Stock and Warrants to Purchase up to 10,838,151 Shares of Common Stock CAPSTONE TURBINE CORPORATION Common Stock (par value $0.001) PLACEMENT AGENT AGREEMENT
Exhibit 1.1
14,450,868 Shares of Common Stock
and Warrants to Purchase up to 10,838,151 Shares of Common Stock
CAPSTONE TURBINE CORPORATION
Common Stock (par value $0.001)
Common Stock (par value $0.001)
PLACEMENT AGENT AGREEMENT
May 4, 2009
LAZARD
CAPITAL MARKETS LLC
00 Xxxxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
00 Xxxxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Dear Sirs:
1. Introduction. Capstone Turbine Corporation, a Delaware corporation (the “Company”), proposes to issue and
sell to the purchasers, pursuant to the terms and conditions of this Placement Agent Agreement
(this “Agreement”) and the Subscription Agreements in the form of Exhibit A attached hereto
(the “Subscription Agreements”) entered into with the purchasers identified therein (each a
“Purchaser” and, collectively, the “Purchasers”), up to an aggregate of 14,450,868 units (the
“Units”), with each Unit consisting of (i) one share of common stock (a “Share” and, collectively,
the “Shares”), $0.001 par value per share (the “Common Stock”) of the Company and (ii) one warrant
to purchase 0.75 a share of Common Stock (the “Warrants”). Units will not be issued or
certificated. The Shares and Warrants are immediately separable and will be issued separately. The
terms and conditions of the Warrants are set forth in the form of Exhibit B attached
hereto. The Shares issuable upon exercise of the Warrants are referred to herein as the “Warrant
Shares” and, together with the Units, the Shares and the Warrants, are referred to herein as the
“Securities.” The Company hereby confirms that Lazard Capital Markets LLC (the “Placement Agent”)
acted as the Placement Agent in accordance with the terms and conditions hereof.
2. Agreement to Act as Placement Agent; Placement of Units. On the basis of the representations, warranties and agreements of the Company herein
contained, and subject to all the terms and conditions of this Agreement:
2.1 The Company has authorized and hereby acknowledges that the Placement Agent has acted as
its exclusive agent to solicit offers for the purchase of all or part of the Units from the
Company in connection with the proposed offering of the Units (the “Offering”). Until the
earlier of the termination of this Agreement or the Closing Date (as defined in Section
4 hereof), the Company shall not, without the prior written consent of the Placement
Agent, solicit or accept offers to purchase Units otherwise than through the Placement Agent.
The Placement Agent may utilize the expertise of Lazard Frères & Co. LLC in connection with
its placement agent activities.
2.2 The Company hereby acknowledges that the Placement Agent, as agent of the Company,
used its reasonable best efforts to solicit offers to purchase the Units from the Company on
the terms and subject to the conditions set forth in the Prospectus (as defined below). The
Placement Agent shall use commercially reasonable efforts to assist the Company in obtaining
performance by each Purchaser whose offer to purchase Units was solicited by the Placement
Agent and accepted by the Company, but the Placement Agent shall not, except as otherwise
provided in this Agreement, be obligated to disclose the identity of any potential purchaser
or have any liability to the Company in the event any such purchase is not consummated for
any reason. Under no circumstances will the Placement Agent be obligated to underwrite or
purchase any Units for its own account and, in soliciting purchases of Units, the Placement
Agent acted solely as the Company’s agent and not as principal. Notwithstanding the
foregoing and except as otherwise provided in Section 2.3, it is understood and
agreed that the Placement Agent (or its affiliates) may, solely at its discretion and without
any obligation to do so, purchase Units from the Company as principal.
2.3 Subject to the provisions of this Section 2, offers for the purchase of
Units were solicited by the Placement Agent as agent for the Company at such times and in
such amounts as the Placement Agent deemed advisable. The Placement Agent communicated to
the Company, orally or in writing, each reasonable offer to purchase Units received by it as
agent of the Company. The Company shall have the sole right to accept offers to purchase the
Units and may reject any such offer, in whole or in part. The Placement Agent has the right,
in its discretion reasonably exercised, without notice to the Company, to reject any offer to
purchase Units received by it, in whole or in part, and any such rejection shall not be
deemed a breach of this Agreement.
2.4 The Units are being sold to the Purchasers at a price of $0.865 per Unit. The
purchases of the Units by the Purchasers shall be evidenced by the execution of the
Subscription Agreements by each of the Purchasers and the Company.
2.5 As compensation for services rendered, on the Closing Date (as defined in
Section 4 hereof), the Company shall pay to the Placement Agent, by wire transfer of
immediately available funds to an account or accounts designated by the Placement Agent, an
aggregate amount (the “Placement Fee”) equal to seven percent (7.0%) of the gross proceeds
received by the Company from the sale of the Units on such Closing Date. For the avoidance
of doubt, the Placement Agent shall not receive any compensation with respect to any proceeds
from the exercise of any Warrants.
2.6 No Units which the Company has agreed to sell pursuant to this Agreement and the
Subscription Agreements shall be deemed to have been purchased and paid for, or sold by the
Company, until such Units shall have been delivered to the Purchaser thereof against payment
by such Purchaser. If the Company shall default in its obligations to deliver the Shares and
Warrants to a Purchaser with whom it has entered into a binding Subscription Agreement, the
Company shall indemnify and hold the Placement Agent harmless against any loss, claim, damage
or expense arising from or as a result of such default by the Company in accordance with the
procedures set forth in Section 8(c) herein.
2
3. Representations and Warranties of the Company. The Company represents and warrants to, and agrees with, the Placement Agent and the
Purchasers that:
(a) The Company has prepared and filed in conformity with the requirements of the
Securities Act of 1933, as amended (the “Securities Act”), and published rules and
regulations thereunder (the “Rules and Regulations”) adopted by the Securities and Exchange
Commission (the “Commission”) a “shelf” Registration Statement (as hereinafter defined) on
Form S-3 (File No. 333-156459), which became effective as of February 4, 2009 (the “Effective
Date”), including a base prospectus relating to the Shares and Warrants (the “Base
Prospectus”), and such amendments and supplements thereto as may have been required to the
date of this Agreement. The term “Registration Statement” as used in this Agreement means the
registration statement (including all exhibits, financial schedules and all documents and
information deemed to be a part of the Registration Statement pursuant to Rule 430A of the
Rules and Regulations), as amended and/or supplemented to the date of this Agreement,
including the Base Prospectus. The Registration Statement is effective under the Securities
Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of the Prospectus has been issued by the
Commission and no proceedings for that purpose have been instituted or, to the knowledge of
the Company, are threatened by the Commission. The Company, if required by the Rules and
Regulations of the Commission, will file the Prospectus (as defined below), with the
Commission pursuant to Rule 424(b) of the Rules and Regulations. The term “Prospectus” as
used in this Agreement means the prospectus, in the form in which it is to be filed with the
Commission pursuant to Rule 424(b) of the Rules and Regulations, or, if the prospectus is not
to be filed with the Commission pursuant to Rule 424(b), the prospectus in the form included
as part of the Registration Statement as of the Effective Date, except that if any revised
prospectus or prospectus supplement shall be provided to the Placement Agent by the Company
for use in connection with the offering and sale of the Units which differs from the
Prospectus (whether or not such revised prospectus or prospectus supplement is required to be
filed by the Company pursuant to Rule 424(b) of the Rules and Regulations), the term
“Prospectus” shall refer to such revised prospectus or prospectus supplement, as the case may
be, from and after the time it is first provided to the Placement Agent for such use. Any
preliminary prospectus or prospectus subject to completion included in the Registration
Statement or filed with the Commission pursuant to Rule 424 of the Rules and Regulations is
hereafter called a “Preliminary Prospectus.” Any reference herein to the Registration
Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to and
include the documents incorporated by reference therein pursuant to Item 12 of Form S-3 which
were filed under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), on or
before the last to occur of the Effective Date, the date of the Preliminary Prospectus, or
the date of the Prospectus, and any reference herein to the terms “amend,” “amendment,” or
“supplement” with respect to the Registration Statement, any Preliminary Prospectus or the
Prospectus shall be deemed to refer to and include (i) the filing of any document under the
Exchange Act after the Effective Date, the date of such Preliminary Prospectus or the date of
the Prospectus, as the case may be, which is incorporated by reference and (ii) any such
document so filed.
3
(b) The conditions to the use of Form S-3 in connection with the offering and sale of
the Securities as contemplated hereby have been satisfied. The Registration Statement meets,
and the offering and sale of the Securities as contemplated hereby complies with, the
requirements of Rule 415 under the Securities Act (including, without limitation, Rule
415(a)(4) and (a)(5) of the Rules and Regulations).
(c) As of the Applicable Time (as defined below) and as of the Closing Date, neither (i)
any General Use Free Writing Prospectus (as defined below) issued at or prior to the
Applicable Time, and the Pricing Prospectus (as defined below) and the information included
on Schedule A hereto, all considered together (collectively, the “General Disclosure
Package”), (ii) any individual Limited Use Free Writing Prospectus (as defined below) nor
(iii) the bona fide electronic road show (as defined in Rule 433(h)(5) of the Rules and
Regulations), if any, that has been made available without restriction to any person, when
considered together with the General Disclosure Package, included or will include, any untrue
statement of a material fact or omitted or as of the Closing Date will omit, to state a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however, that the Company
makes no representations or warranties as to information contained in or omitted from any
Issuer Free Writing Prospectus, in reliance upon, and in conformity with, written information
furnished to the Company by the Placement Agent specifically for inclusion therein, which
information the parties hereto agree is limited to the Placement Agent’s Information (as
defined in Section 17). As used in this paragraph (b) and elsewhere in this
Agreement:
“Applicable Time” means 8:00 A.M., New York time, on the date of this Agreement.
“General Use Free Writing Prospectus” means any Issuer Free Writing Prospectus that is
identified on Schedule A to this Agreement.
“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as defined in
Rule 433 of the Rules and Regulations relating to the Units in the form filed or required to
be filed with the Commission or, if not required to be filed, in the form retained in the
Company’s records pursuant to Rule 433(g) of the Rules and Regulations.
“Limited Use Free Writing Prospectuses” means any Issuer Free Writing Prospectus that is not
a General Use Free Writing Prospectus.
“Pricing Prospectus” means the Preliminary Prospectus, if any, and the Base Prospectus, each
as amended and supplemented immediately prior to the Applicable Time, including any document
incorporated by reference therein and any prospectus supplement deemed to be a part thereof.
(d) No order preventing or suspending the use of any Preliminary Prospectus, any Issuer
Free Writing Prospectus or the Prospectus relating to the Offering has been issued by the
Commission, and no proceeding for that purpose or pursuant to Section 8A of the Securities
Act has been instituted or, to the knowledge of the Company, threatened by the Commission,
and each Preliminary Prospectus (if any), at the time of filing
4
thereof, conformed in all material respects to the requirements of the Securities Act and the
Rules and Regulations, and did not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements
therein, in the light of the circumstances under which they were made, not misleading;
provided, however, that the Company makes no representations or warranties as to information
contained in or omitted from any Preliminary Prospectus, in reliance upon, and in conformity
with, written information furnished to the Company by the Placement Agent specifically for
inclusion therein, which information the parties hereto agree is limited to the Placement
Agent’s Information (as defined in Section 17).
(e) At the time the Registration Statement became effective, at the date of this
Agreement and at the Closing Date, the Registration Statement conformed and will conform in
all material respects to the requirements of the Securities Act and the Rules and Regulations
and did not and will not contain any untrue statement of a material fact or omit to state any
material fact required to be stated therein or necessary to make the statements therein not
misleading; the Prospectus, at the time the Prospectus was issued and at the Closing Date,
conformed and will conform in all material respects to the requirements of the Securities Act
and the Rules and Regulations and did not and will not contain an untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading; provided,
however, that the foregoing representations and warranties in this paragraph (e)
shall not apply to information contained in or omitted from the Registration Statement or the
Prospectus in reliance upon, and in conformity with, written information furnished to the
Company by the Placement Agent specifically for inclusion therein, which information the
parties hereto agree is limited to the Placement Agent’s Information (as defined in
Section 17).
(f) Each Issuer Free Writing Prospectus, if any, as of its issue date and at all
subsequent times through the completion of the Offering or until any earlier date that the
Company notified or notifies the Placement Agent as described in Section 5(e), did
not, does not and will not include any information that conflicted, conflicts or will
conflict with the information contained in the Registration Statement, Pricing Prospectus or
the Prospectus, including any document incorporated by reference therein and any prospectus
supplement deemed to be a part thereof that has not been superseded or modified, or includes
an untrue statement of a material fact or omitted or would omit to state a material fact
required to be stated therein or necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading. The foregoing
sentence does not apply to statements in or omissions from any Issuer Free Writing Prospectus
in reliance upon, and in conformity with, written information furnished to the Company by the
Placement Agent specifically for inclusion therein, which information the parties hereto
agree is limited to the Placement Agent’s Information (as defined in Section 17).
(g) The documents incorporated by reference in the Prospectus, when they became
effective or were filed with the Commission, as the case may be, conformed in all material
respects to the requirements of the Securities Act or the Exchange Act, as applicable, and
the rules and regulations of the Commission thereunder and none of such
5
documents contained any untrue statement of a material fact or omitted to state any material
fact required to be stated therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not misleading; and any further documents so
filed and incorporated by reference in the Prospectus, when such documents become effective
or are filed with the Commission, as the case may be, will conform in all material respects
to the requirements of the Securities Act or the Exchange Act, as applicable, and the rules
and regulations of the Commission thereunder and will not contain any untrue statement of a
material fact or omit to state any material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances under which they were made, not
misleading.
(h) The Company has not, directly or indirectly, distributed and will not distribute any
offering material in connection with the Offering other than any Preliminary Prospectus, the
Prospectus and other materials, if any, permitted under the Securities Act and consistent
with Section 5(b) below. The Company is not an “ineligible issuer” in connection with
the offering pursuant to Rules 164, 405 and 433 under the Securities Act. The Company will
file with the Commission all Issuer Free Writing Prospectuses (other than a “road show,” as
described in Rule 433(d)(8) of the Rules and Regulations), if any, in the time and manner
required under Rules 163(b)(2) and 433(d) of the Rules and Regulations.
(i) The Company and each of its subsidiaries (as defined in Section 15) have
been duly organized and are validly existing as corporations in good standing (or the foreign
equivalent thereof) under the laws of their respective jurisdictions of organization. The
Company and each of its subsidiaries are duly qualified to do business and are in good
standing as foreign corporations in each jurisdiction in which their respective ownership or
lease of property or the conduct of their respective businesses requires such qualification
and have all corporate power and authority necessary to own or hold their respective
properties and to conduct the businesses in which they are engaged, except where the failure
to so qualify or have such power or authority would not (i) have, singularly or in the
aggregate, a material adverse effect on the condition (financial or otherwise), results of
operations, assets, business or prospects of the Company and its subsidiaries taken as a
whole, or (ii) impair in any material respect the ability of the Company to perform its
obligations under this Agreement or to consummate any transactions contemplated by this
Agreement, the General Disclosure Package or the Prospectus (any such effect as described in
clauses (i) or (ii), a “Material Adverse Effect”). The Company owns or controls, directly or
indirectly, only the following corporations, partnerships, limited liability partnerships,
limited liability companies, associations or other entities: Capstone Turbine International,
Inc., a Delaware corporation.
(j) The Company has the full right, power and authority to enter into this Agreement and
each of the Subscription Agreements, and to perform and to discharge its obligations
hereunder and thereunder; and each of this Agreement and each of the Subscription Agreements
has been duly authorized, executed and delivered by the Company, and , once executed by the
counterparties thereto, will constitute a valid and binding obligation of the Company
enforceable in accordance with its terms, except as
6
such enforceability may be limited by applicable bankruptcy, insolvency, reorganization or
other similar laws relating to the enforcement of creditors’ rights generally, and general
equitable principles relating to the availability of remedies, and except as rights of
indemnity or contribution may be limited by federal or state securities laws and the public
policy underlying such laws.
(k) The Shares and the Warrants to be issued and sold by the Company to the Purchasers
hereunder and under the Subscription Agreements have been duly and validly authorized and,
when issued and delivered against payment therefor as provided herein and in the Subscription
Agreements, and the Warrant Shares, when issued and delivered against payment therefor as
provided in the Warrants, will be duly and validly issued, fully paid and non-assessable and
free of any preemptive or similar rights and will conform to the description thereof
contained in the General Disclosure Package and the Prospectus.
(l) The Company has an authorized capitalization as set forth in the Pricing Prospectus,
and all of the issued and outstanding shares of capital stock of the Company have been duly
and validly authorized and issued, are fully paid and non-assessable, have been issued in
compliance with federal and state securities laws, and conform to the description thereof
contained in the General Disclosure Package and the Prospectus. As of April 30, 2009, there
were 174,100,629 shares of Common Stock issued and outstanding and no shares of Preferred
Stock, par value $0.001 of the Company issued and outstanding and 32,455,560 shares of Common
Stock were issuable upon the exercise of all options, warrants and convertible securities
outstanding as of such date. Since such date, the Company has not issued any securities,
other than Common Stock of the Company issued pursuant to the exercise of stock options
previously outstanding under the Company’s stock option plans or the issuance of Common Stock
pursuant to employee stock purchase plans. All of the Company’s options, warrants and other
rights to purchase or exchange any securities for shares of the Company’s capital stock have
been duly authorized and validly issued and were issued in compliance with US federal and
state securities laws. None of the outstanding shares of Common Stock was issued in
violation of any preemptive rights, rights of first refusal or other similar rights to
subscribe for or purchase securities of the Company, except for such rights as may have been
fully satisfied or waived. There are no authorized or outstanding shares of capital stock,
options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or
equity or debt securities convertible into or exchangeable or exercisable for, any capital
stock of the Company or any of its subsidiaries other than those described above or
accurately described in the General Disclosure Package. The description of the Company’s
stock option, stock bonus and other stock plans or arrangements, and the options or other
rights granted thereunder, as described in the General Disclosure Package and the Prospectus,
accurately and fairly present the information required to be shown with respect to such
plans, arrangements, options and rights. The Rights Agreement dated as of July 7, 2005 and
Amendment No. 1 thereto dated as of July 3, 2008, each between the Company and Mellon
Investor Services LLC (collectively the “Rights Agreement”) have been duly authorized,
executed and delivered by, and are valid and binding agreements of, the Company, enforceable
in accordance with their terms, except as such enforceability may be limited by bankruptcy,
insolvency,
7
reorganization, moratorium or similar laws affecting the rights and remedies of creditors
generally and by general principles of equity; one “Right” (as such term is defined in the
Rights Agreement) has been issued in respect of each outstanding share of Common Stock and is
evidenced by the certificate for that share of Common Stock; one Right will be issued in
respect of each share of Common Stock issued by the Company and will be evidenced by the
certificate for that share of Common Stock; and one Right will be issued in respect of each
Warrant Share issued by the Company and will be evidenced by the certificate for that Warrant
Share.
(m) All the outstanding shares of capital stock of each subsidiary of the Company have
been duly authorized and validly issued, are fully paid and nonassessable and, except to the
extent set forth in the General Disclosure Package or the Prospectus, are owned by the
Company directly or indirectly through one or more wholly-owned subsidiaries, free and clear
of any claim, lien, encumbrance, security interest, restriction upon voting or transfer or
any other claim of any third party.
(n) The execution, delivery and performance of this Agreement and the Subscription
Agreements by the Company, the issuance and sale of the Units by the Company and the
consummation of the transactions contemplated hereby and thereby will not (with or without
notice or lapse of time or both) conflict with or result in a breach or violation of any of
the terms or provisions of, constitute a default or Debt Repayment Triggering Event (as
defined below) under, give rise to any right of termination or other right or the
cancellation or acceleration of any right or obligation or loss of a benefit under, or give
rise to the creation or imposition of any lien, encumbrance, security interest, claim or
charge upon any property or assets of the Company or any subsidiary pursuant to, any
indenture, mortgage, deed of trust, loan agreement or other agreement or instrument to which
the Company or any of its subsidiaries is a party or by which the Company or any of its
subsidiaries is bound or to which any of the property or assets of the Company or any of its
subsidiaries is subject, except, to such extent as, individually or in the aggregate, does
not have a Material Adverse Effect, nor will such actions result in any violation of the
provisions of the charter or by-laws (or analogous governing instruments, as applicable) of
the Company or any of its subsidiaries or any law, statute, rule, regulation, judgment, order
or decree of any court or governmental agency or body, domestic or foreign, having
jurisdiction over the Company or any of its subsidiaries or any of their properties or
assets, except where any such conflict, breach, violation, default or right could not
reasonably be expected to have a Material Adverse Effect. A “Debt Repayment Triggering
Event” means any event or condition that gives, or with the giving of notice or lapse of time
would give the holder of any note, debenture or other evidence of indebtedness (or any person
acting on such holder’s behalf) the right to require the repurchase, redemption or repayment
of all or a portion of such indebtedness by the Company or any of its subsidiaries.
(o) Except for the registration of the Units under the Securities Act and such consents,
approvals, authorizations, registrations or qualifications as may be required under the
Exchange Act and applicable state or foreign securities laws, the Financial Industry
Regulatory Authority (“FINRA”) and the Nasdaq Global Market in connection with the offering
and sale of the Units by the Company, no consent, approval,
8
authorization or order of, or filing, qualification or registration with, any court or
governmental agency or body, foreign or domestic, which has not been made, obtained or taken
and is not in full force and effect, is required for the execution, delivery and performance
of this Agreement and the Subscription Agreements by the Company, the offer or sale of the
Units or the consummation of the transactions contemplated hereby or thereby.
(p) Deloitte & Touche LLP, who have certified certain financial statements and related
schedules included or incorporated by reference in the Registration Statement, the General
Disclosure Package and the Prospectus, and has audited the Company’s internal control over
financial reporting and management’s assessment thereof, is an independent registered public
accounting firm as required by the Securities Act and the Rules and Regulations and the
Public Company Accounting Oversight Board (United States) (the “PCAOB”). Except as
pre-approved in accordance with the requirements set forth in Section 10A of the Exchange
Act, Deloitte & Touche LLP has not been engaged by the Company to perform any “prohibited
activities” (as defined in Section 10A of the Exchange Act).
(q) The financial statements, together with the related notes and schedules, included or
incorporated by reference in the General Disclosure Package, the Prospectus and in the
Registration Statement fairly present the financial position and the results of operations
and changes in financial position of the Company and its consolidated subsidiaries and other
consolidated entities at the respective dates or for the respective periods therein
specified. Such statements and related notes and schedules have been prepared in accordance
with the generally accepted accounting principles in the United States (“GAAP”) applied on a
consistent basis throughout the periods involved except as may be set forth in the related
notes included or incorporated by reference in the General Disclosure Package. The financial
statements, together with the related notes and schedules, included or incorporated by
reference in the General Disclosure Package and the Prospectus comply in all material
respects with the Securities Act, the Exchange Act, and the Rules and Regulations and the
rules and regulations under the Exchange Act. No other financial statements or supporting
schedules or exhibits are required by the Securities Act or the Rules and Regulations to be
described, or included or incorporated by reference in the Registration Statement, the
General Disclosure Package or the Prospectus. There is no pro forma or as adjusted financial
information which is required to be included in the Registration Statement, the General
Disclosure Package, or and the Prospectus or a document incorporated by reference therein in
accordance with the Securities Act and the Rules and Regulations which has not been included
or incorporated as so required.
(r) Neither the Company nor any of its subsidiaries has sustained, since the date of the
latest audited financial statements included or incorporated by reference in the General
Disclosure Package, any material loss or interference with its business from fire, explosion,
flood or other calamity, whether or not covered by insurance, or from any labor dispute or
court or governmental action, order or decree, otherwise than as set forth or contemplated in
the General Disclosure Package; and, since such date, there has not been any change in the
capital stock (other than as a result of the issuance of Common
9
Stock issued pursuant to the exercise of stock options under the Company’s stock plans, the
issuance of Common Stock under the Company’s stock plans, and the issuance of Common Stock
pursuant to employee stock purchase plans, in each case, in the ordinary course of business)
or long-term debt of the Company or any of its subsidiaries, or any Material Adverse Effect,
otherwise than as set forth or contemplated in the General Disclosure Package.
(s) Except as set forth in the General Disclosure Package, there is no legal or
governmental action, suit, claim or proceeding pending to which the Company or any of its
subsidiaries is a party or of which any property or assets of the Company or any of its
subsidiaries is the subject which is required to be described in the Registration Statement,
the General Disclosure Package or the Prospectus or a document incorporated by reference
therein and is not described therein, or which, singularly or in the aggregate, if determined
adversely to the Company or any of its subsidiaries, could reasonably be expected to have a
Material Adverse Effect or prevent or adversely affect the ability of the Company to perform
its obligations under this Agreement or the consummation of the transactions contemplated
hereby; and to the best of the Company’s knowledge, no such proceedings are threatened or
contemplated by governmental authorities or threatened by others.
(t) Neither the Company nor any of its subsidiaries is in (i) violation of its charter
or by-laws (or analogous governing instrument, as applicable), (ii) default in any respect,
and no event has occurred which, with notice or lapse of time or both, would constitute such
a default, in the due performance or observance of any term, covenant or condition contained
in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or
instrument to which it is a party or by which it is bound or to which any of its property or
assets is subject or (iii) violation in any respect of any statute, law, ordinance,
governmental rule, regulation or court order, decree or judgment to which it or its property
or assets may be subject except, in the case of clauses (ii) and (iii) of this paragraph (t),
for any violations or defaults which, singularly or in the aggregate, could not reasonably be
expected to have a Material Adverse Effect.
(u) The Company and each of its subsidiaries possesses all licenses, certificates,
authorizations and permits issued by, and have made all declarations and filings with, the
appropriate local, state, federal or foreign regulatory agencies or bodies which are
necessary or desirable for the ownership of their respective properties or the conduct of
their respective businesses as described in the General Disclosure Package and the Prospectus
(collectively, the “Governmental Permits”) except where any failures to possess or make the
same, singularly or in the aggregate, would not have a Material Adverse Effect. The Company
and its subsidiaries are in material compliance with all such Governmental Permits; all such
Governmental Permits are valid and in full force and effect, except where the validity or
failure to be in full force and effect could not, singularly or in the aggregate, reasonably
be expected to have a Material Adverse Effect. All such Governmental Permits are free and
clear of any restriction or condition that are in addition to, or materially different from
those normally applicable to similar licenses, certificates, authorizations and permits.
Neither the Company nor any subsidiary has received notification of any revocation or
modification (or proceedings related thereto) of
10
any such Governmental Permit and the Company has no knowledge that any such Governmental
Permit will not be renewed.
(v) Neither the Company nor any of its subsidiaries is or, after giving effect to the
offering and sale of the Securities, including the issuance, offering and sale of the Warrant
Shares, and the application of the proceeds thereof as described in the General Disclosure
Package and the Prospectus, will become an “investment company” within the meaning of the
Investment Company Act of 1940, as amended, and the rules and regulations of the Commission
thereunder.
(w) The Company is not and, after giving effect to the offering and sale of the
Securities, will not be a “holding company,” or a “subsidiary company” of a “holding
company,” or an “affiliate” of a “holding company” or of a “subsidiary company,” as such
terms are defined in the Public Utility Holding Company Act of 1935, as amended.
(x) Neither the Company, its subsidiaries nor, to the Company’s knowledge, any of the
Company’s or its subsidiaries’ officers, directors or affiliates has taken or will take,
directly or indirectly, any action designed or intended to stabilize or manipulate the price
of any security of the Company, or which caused or resulted in, or which might in the future
reasonably be expected to cause or result in, stabilization or manipulation of the price of
any security of the Company.
(y) Except as disclosed in, or incorporated by reference into, the Registration
Statement or the Prospectus, the Company and its subsidiaries owns or possesses the right to
use all patents, trademarks, trademark registrations, service marks, service xxxx
registrations, trade names, copyrights, licenses, inventions, software, databases, know-how,
Internet domain names, trade secrets and other unpatented and/or unpatentable proprietary or
confidential information, systems or procedures, and other intellectual property
(collectively, “Intellectual Property”) necessary to carry on their respective businesses as
currently conducted, and as proposed to be conducted and described in the General Disclosure
Package and the Prospectus, and the Company has no knowledge of any claim to the contrary or
any challenge by any other person to the rights of the Company and its subsidiaries with
respect to the foregoing except for those that could not reasonably be expected to have a
Material Adverse Effect. The Intellectual Property licenses described in the General
Disclosure Package and the Prospectus are valid, binding upon, and enforceable by or against
the Company, and, to the Company’s knowledge, the other parties thereto in accordance to its
terms, except as such enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting the enforcement of creditors
rights generally and subject to general principles of equity. The Company and each of its
subsidiaries has complied in all material respects with, and are not in breach and have not
received any asserted or threatened claim of breach of, any Intellectual Property license,
and the Company has no knowledge of any breach or anticipated breach by any other person to
any Intellectual Property license. The Company’s and each of its subsidiaries’ businesses as
now conducted and as proposed to be conducted does not and will not infringe or conflict with
any patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses or
other Intellectual Property of any person. No claim has been made against the Company
11
or any of its subsidiaries alleging the infringement by the Company or any of its
subsidiaries of any patent, trademark, service xxxx, trade name, copyright, trade secret,
license in or other intellectual property right or franchise right of any person. The
Company and each of its subsidiaries has taken all reasonable steps to protect, maintain and
safeguard its rights in all Intellectual Property, including the execution of appropriate
nondisclosure and confidentiality agreements. The consummation of the transactions
contemplated by this Agreement will not result in the loss or impairment of or payment of any
additional amounts with respect to, nor require the consent of any other person in respect
of, the Company’s or any of its subsidiaries’ right to own, use, or hold for use any of the
Intellectual Property as owned, used or held for use in the conduct of the businesses as
currently conducted. Except as would not cause a Material Adverse Effect, with respect to
the use of the software in the Company’s or any of its subsidiaries’ businesses as they are
currently conducted, the Company nor any of its subsidiaries has experienced any material
defects in such software including any material error or omission in the processing of any
transactions other than defects which have been corrected, and to the knowledge of the
Company, no such software contains any device or feature designed to disrupt, disable, or
otherwise impair the functioning of any software or is subject to the terms of any “open
source” or other similar license that provides for the source code of the software to be
publicly distributed or dedicated to the public. The Company and each of its subsidiaries
has at all times complied in all material respects with all applicable laws relating to
privacy, data protection, and the collection and use of personal information collected, used,
or held for use by the Company and any of its subsidiaries in the conduct of the Company’s
and its subsidiaries businesses. No claims have been asserted or, to the knowledge of the
Company, threatened against the Company or any of its subsidiaries alleging a violation of
any person’s privacy or personal information or data rights and the consummation of the
transactions contemplated hereby will not breach or otherwise cause any violation of any law
related to privacy, data protection, or the collection and use of personal information
collected, used, or held for use by the Company or any of its subsidiaries in the conduct of
the Company’s or any of its subsidiaries’ businesses. The Company and each of its
subsidiaries takes reasonable measures to ensure that such information is protected against
unauthorized access, use, modification, or other misuse.
(z) Neither the Company nor its subsidiaries own any real property. The Company and
each of its subsidiaries have good and marketable title in fee simple to, or have valid
rights to lease or otherwise use, all items of real or personal property, which are material
to the business of the Company and its subsidiaries taken as a whole, in each case free and
clear of all liens, encumbrances, security interests, claims and defects that do not,
singularly or in the aggregate, materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the
Company or any of its subsidiaries; and all of the leases and subleases material to the
business of the Company and its subsidiaries, considered as one enterprise, and under which
the Company or any of its subsidiaries holds properties described in the General Disclosure
Package and the Prospectus, are in full force and effect, and neither the Company nor any
subsidiary has received any notice of any material claim of any sort that has been asserted
by anyone adverse to the rights of the Company or any subsidiary under any of the leases or
subleases mentioned above, or affecting or questioning the
12
rights of the Company or such subsidiary to the continued possession of the leased or
subleased premises under any such lease or sublease.
(aa) No labor disturbance by the employees of the Company or any of its subsidiaries
exists or, to the best of the Company’s knowledge, is threatened or imminent, and the Company
does not have knowledge of any existing or imminent labor disturbance by the employees of any
of its or its subsidiaries’ principal suppliers, manufacturers, customers or contractors,
that could reasonably be expected, singularly or in the aggregate, to have a Material Adverse
Effect. To the Company’s knowledge, no key employee or significant group of employees of the
Company or any subsidiary plans to terminate employment with the Company or any such
subsidiary.
(bb) No “prohibited transaction” (as defined in Section 406 of the Employee Retirement
Income Security Act of 1974, as amended, including the regulations and published
interpretations thereunder (“ERISA”), or Section 4975 of the Internal Revenue Code of 1986,
as amended from time to time (the “Code”)) or “accumulated funding deficiency” (as defined in
Section 302 of ERISA) or any of the events set forth in Section 4043(b) of ERISA (other than
events with respect to which the thirty (30)-day notice requirement under Section 4043 of
ERISA has been waived) has occurred or could reasonably be expected to occur with respect to
any employee benefit plan of the Company or any of its subsidiaries which could, singularly
or in the aggregate, have a Material Adverse Effect. Each employee benefit plan of the
Company or any of its subsidiaries is in compliance in all material respects with applicable
law, including ERISA and the Code. The Company and its subsidiaries have not incurred and
could not reasonably be expected to incur liability under Title IV of ERISA with respect to
the termination of, or withdrawal from, any pension plan (as defined in ERISA). Each pension
plan for which the Company or any of its subsidiaries would have any liability that is
intended to be qualified under Section 401(a) of the Code is so qualified, and nothing has
occurred, whether by action or by failure to act, which could, singularly or in the
aggregate, cause the loss of such qualification.
(cc) The Company and its subsidiaries are in compliance with all foreign, federal, state
and local rules, laws and regulations relating to the use, treatment, storage and disposal of
hazardous or toxic substances or waste and protection of health and safety or the environment
which are applicable to their businesses (“Environmental Laws”), except where the failure to
comply could not, singularly or in the aggregate, reasonably be expected to have a Material
Adverse Effect. There has been no storage, generation, transportation, handling, treatment,
disposal, discharge, emission, or other release of any kind of toxic or other wastes or other
hazardous substances by, due to, or caused by the Company or any of its subsidiaries (or, to
the Company’s knowledge, any other entity for whose acts or omissions the Company or any of
its subsidiaries is or may otherwise be liable) upon any of the property now or previously
owned or leased by the Company or any of its subsidiaries, or upon any other property, in
violation of any law, statute, ordinance, rule, regulation, order, judgment, decree or permit
or which would, under any law, statute, ordinance, rule (including rule of common law),
regulation, order, judgment, decree or permit, give rise to any liability, except for any
violation or liability which would not have, singularly or in the aggregate with all such
violations and liabilities, a
13
Material Adverse Effect; and there has been no disposal, discharge, emission or other release
of any kind onto such property or into the environment surrounding such property of any toxic
or other wastes or other hazardous substances with respect to which the Company has
knowledge, except for any such disposal, discharge, emission, or other release of any kind
which would not have, singularly or in the aggregate with all such discharges and other
releases, a Material Adverse Effect. In the ordinary course of business, the Company and its
subsidiaries conduct periodic reviews of the effect of Environmental Laws on their business
and assets, in the course of which they identify and evaluate associated costs and
liabilities (including, without limitation, any capital or operating expenditures required
for clean-up, closure of properties or compliance with Environmental Laws or Governmental
Permits issued thereunder, any related constraints on operating activities and any potential
liabilities to third parties). On the basis of such reviews, the Company and its
subsidiaries have reasonably concluded that such associated costs and liabilities could not
reasonably be expected to have, singularly or in the aggregate, a Material Adverse Effect.
(dd) The Company and its subsidiaries, each (i) has timely filed all necessary federal,
state, local and foreign tax returns (or have received such permissible extensions to file),
and all such returns were true, complete and correct in all material respects, (ii) has paid
all federal, state, local and foreign taxes, assessments, governmental or other charges due
and payable to a government entity in the nature of a tax for which it is liable, including,
without limitation, all sales and use taxes and all taxes which the Company or any of its
subsidiaries is obligated to withhold from amounts owing to employees, creditors and third
parties, and (iii) does not have any tax deficiency or claims outstanding or assessed or, to
the best of its knowledge, proposed against any of them, except those, in each of the cases
described in clauses (i), (ii) and (iii) of this paragraph (dd), that would not,
singularly or in the aggregate, have a Material Adverse Effect. The Company and its
subsidiaries, each has not engaged in any transaction which is a corporate tax shelter or
which could be characterized as such by the Internal Revenue Service or any other taxing
authority. The accruals and reserves on the books and records of the Company and its
subsidiaries in respect of tax liabilities for any taxable period not yet finally determined
are adequate to meet any assessments and related liabilities for any such period, and since
March 31, 2008, the Company and its subsidiaries each has not incurred any liability for
taxes other than in the ordinary course.
(ee) The Company and each of its subsidiaries carries, or is covered by, insurance
provided by licensed insurers with policies in such amounts and covering such risks as is
adequate for the conduct of their respective businesses and the value of their respective
properties and as is customary for companies engaged in similar businesses in similar
industries. The Company has no reason to believe that it or any subsidiary will not be able
(i) to renew its existing insurance coverage as and when such policies expire or (ii) to
obtain comparable coverage from similar institutions as may be necessary or appropriate to
conduct its business as now conducted and at a cost that would not result in a Material
Adverse Effect.
(ff) The Company maintains a system of internal control over financial reporting (as
such term is defined in Rule 13a-15 of the rules and regulations under the
14
Exchange Act) that complies with the requirements of the Exchange Act and that has been
designed by the Company’s principal executive officer and principal financial officer, or
under their supervision to provide reasonable assurances that (i) transactions are executed
in accordance with management’s general or specific authorizations; (ii) transactions are
recorded as necessary to permit preparation of financial statements in conformity with GAAP
and to maintain accountability for assets; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences. Except as described in the
General Disclosure Package, since the end of the Company’s most recent audited fiscal year,
there has been (A) no material weakness in the Company’s internal control over financial
reporting (whether or not remediated) and (B) no change in the Company’s internal control
over financial reporting that has materially affected, or is reasonably likely to materially
affect, the Company’s internal control over financial reporting.
(gg) The Company has received no written comments from the Commission staff regarding
its periodic or current reports under the Exchange Act that remain unresolved.
(hh) The minute books of the Company and each of its subsidiaries that would be a
“significant subsidiary” within the meaning of Rule 1-02(w) of Regulation S-X under the
Exchange Act (such a significant subsidiary of the Company, a “Significant Subsidiary”) have
been made available to the Placement Agent and counsel for the Placement Agent, and such
books (i) contain a complete summary of all meetings and actions of the board of directors
(including each board committee) and shareholders of the Company (or analogous governing
bodies and interest holders, as applicable), and each of its Significant Subsidiaries since
the time of its respective incorporation or organization through the date of the latest
meeting and action, and (ii) accurately in all material respects reflect all transactions
referred to in such minutes. There are no material transactions, agreements or other actions
of the Company or of its subsidiaries that are not properly approved and/or recorded in the
minute books of the Company or of its subsidiaries, as applicable.
(ii) There is no franchise, lease, contract, agreement or document required by the
Securities Act or by the Rules and Regulations to be described in the General Disclosure
Package and in the Prospectus or a document incorporated by reference therein or to be filed
as an exhibit to the Registration Statement or a document incorporated by reference therein
which is not described or filed therein as required; and all descriptions of any such
franchises, leases, contracts, agreements or documents contained in the Registration
Statement or in a document incorporated by reference therein are accurate and complete
descriptions of such documents in all material respects. Other than as described in the
General Disclosure Package, no such franchise, lease, contract or agreement has been
suspended or terminated for convenience or default by the Company or any of its subsidiaries
or any of the other parties thereto, and neither the Company nor any of its subsidiaries has
received notice nor does the Company have any other knowledge of any such pending or
threatened suspension, termination or non-
15
renewal, except for such pending or threatened suspensions, terminations or non-renewals that
would not reasonably be expected to, singularly or in the aggregate, have a Material Adverse
Effect.
(jj) No relationship, direct or indirect, exists between or among the Company and any of
its subsidiaries on the one hand, and the directors, officers, stockholders (or analogous
interest holders), customers or suppliers of the Company or any of its subsidiaries or any of
their affiliates on the other hand, which is required to be described in the General
Disclosure Package and the Prospectus or a document incorporated by reference therein and
which is not so described.
(kk) No person or entity has the right to require registration of shares of Common Stock
or other securities of the Company or any of its subsidiaries because of the filing or
effectiveness of the Registration Statement or the Offering, except for persons and entities
who have expressly waived such right in writing or who have been given timely and proper
written notice and have failed to exercise such right within the time or times required under
the terms and conditions of such right. Except as described in the General Disclosure
Package, there are no persons with registration rights or similar rights to have any
securities registered by the Company or any of its subsidiaries under the Securities Act.
(ll) Neither the Company nor any of its subsidiaries own any “margin securities” as that
term is defined in Regulation U of the Board of Governors of the Federal Reserve System (the
“Federal Reserve Board”), and none of the proceeds of the sale of the Units will be used,
directly or indirectly, for the purpose of purchasing or carrying any margin security, for
the purpose of reducing or retiring any indebtedness which was originally incurred to
purchase or carry any margin security or for any other purpose which might cause any of the
Units to be considered a “purpose credit” within the meanings of Regulation T, U or X of the
Federal Reserve Board.
(mm) Neither the Company nor any of its subsidiaries is a party to any contract,
agreement or understanding with any person (other than this Agreement and any letter of
understanding between the Company and the Placement Agent) that would give rise to a valid
claim against the Company or the Placement Agent for a brokerage commission, finder’s fee or
like payment in connection with the offering and sale of the Units or any transaction
contemplated by this Agreement, the Registration Statement, the General Disclosure Package or
the Prospectus.
(nn) No forward-looking statement (within the meaning of Section 27A of the Securities
Act and Section 21E of the Exchange Act) contained in either the General Disclosure Package
or the Prospectus has been made or reaffirmed without a reasonable basis or has been
disclosed other than in good faith.
(oo) The Company is subject to and in compliance in all material respects with the
reporting requirements of Section 13 or Section 15(d) of the Exchange Act. The Common Stock
is registered pursuant to Section 12(b) of the Exchange Act and is listed on the Nasdaq
Global Market (the “NasdaqGM”), and, since the date which is twelve
16
(12) months prior to the date of this Agreement, the Company has taken no action designed to,
or reasonably likely to have the effect of, terminating the registration of the Common Stock
under the Exchange Act or delisting the Common Stock from the NasdaqGM, nor has the Company
received any notification that the Commission or the Nasdaq Stock Market LLC is contemplating
terminating such registration or listing. No consent, approval, authorization or order of,
or filing, notification or registration with, the NasdaqGM is required for the listing and
trading of the Units on the NasdaqGM, except for (i) a Notification Form: Listing of
Additional Shares and (ii) a Notification Form: Change in the Number of Shares Outstanding.
(pp) The Company is in compliance with all applicable provisions of the Xxxxxxxx-Xxxxx
Act of 2002 and all rules and regulations promulgated thereunder or implementing the
provisions thereof (the “Xxxxxxxx-Xxxxx Act”).
(qq) The Company is in compliance with all applicable corporate governance requirements
set forth in the Nasdaq Marketplace Rules.
(rr) Neither the Company nor any of its subsidiaries nor, to the best of the Company’s
knowledge, any employee or agent of the Company or any subsidiary, has not made any
contribution or other payment to any official of, or candidate for, any federal, state, local
or foreign office in violation of any law (including the Foreign Corrupt Practices Act of
1977, as amended) or of the character required to be disclosed in the Registration Statement,
the General Disclosure Package or the Prospectus or a document incorporated by reference
therein.
(ss) There are no transactions, arrangements or other relationships between and/or among
the Company, any of its affiliates (as such term is defined in Rule 405 of the Securities
Act) and any unconsolidated entity, including, but not limited to, any structured finance,
special purpose or limited purpose entity that could reasonably be expected to materially
affect the Company’s or any of its subsidiaries’ liquidity or the availability of or
requirements for their capital resources required to be described in the General Disclosure
Package and the Prospectus or a document incorporated by reference therein which have not
been described as required.
(tt) There are no outstanding loans, advances (except normal advances for business
expenses in the ordinary course of business) or guarantees or indebtedness by the Company or
any of its subsidiaries to or for the benefit of any of the officers or directors of the
Company, any of its subsidiaries or any of their respective family members, except as
disclosed in the Registration Statement, the General Disclosure Package and the Prospectus.
(uu) The statistical and market-related data included in the Registration Statement, the
General Disclosure Package and the Prospectus are based on or derived from sources that the
Company believes to be reliable and accurate.
(vv) The operations of the Company and its subsidiaries are and have been conducted at
all times in compliance with applicable financial recordkeeping and
17
reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as
amended, applicable money laundering statutes and applicable rules and regulations thereunder
(collectively, the “Money Laundering Laws”), and no action, suit or proceeding by or before
any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Money Laundering Laws is pending, or to the
knowledge of the Company, threatened.
(ww) Neither the Company nor any of its subsidiaries nor, to the knowledge of the
Company, any director, officer, agent, employee or affiliate of the Company or any of its
subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign
Assets Control of the U.S. Treasury Department (“OFAC”); and the Company will not directly or
indirectly use the proceeds of the offering, or lend, contribute or otherwise make available
such proceeds to any subsidiary, joint venture partner or other person or entity, for the
purpose of financing the activities of any person currently subject to any U.S. sanctions
administered by OFAC.
(xx) Neither the Company nor any subsidiary nor any of their affiliates (within the
meaning of FINRA Conduct Rule 2720(b)(1)(a)) directly or indirectly controls, are controlled
by, or is under common control with, or is an associated person (within the meaning of
Article I, Section 1(ee) of the By-laws of FINRA) of, any member firm of FINRA.
(yy) No customer of or supplier to the Company or any of its subsidiaries has ceased
purchases or shipments of merchandise to the Company or indicated, to the Company’s
knowledge, an interest in decreasing or ceasing its purchases from or sales to the Company or
otherwise modifying its relationship with the Company, other than in the normal and ordinary
course of business consistent with past practices in a manner which would not, singly or in
the aggregate, result in a Material Adverse Effect.
(zz) The Company satisfies the pre-1992 eligibility requirements for the use of a
registration statement on Form S-3 in connection with the Offering contemplated thereby (the
pre-1992 eligibility requirements for the use of the registration statement on Form S-3
include (i) having a non-affiliate, public common equity float of at least $150 million or a
non-affiliate, public common equity float of at least $100 million and annual trading volume
of at least three million shares and (ii) having been subject to the Exchange Act reporting
requirements for a period of 36 months).
(aaa) Assuming the accuracy of the representations and warranties of the Purchasers in
the Subscription Agreements, no approval of the shareholders of the Company under the rules
and regulations of Nasdaq (including Rule 4350 of the Nasdaq Global Marketplace Rules) is
required for the Company to issue and deliver to the Purchasers the Units.
Any certificate signed by or on behalf of the Company and delivered to the Placement Agent or
to counsel for the Placement Agent shall be deemed to be a representation and warranty by the
Company to the Placement Agent and the Purchasers as to the matters covered thereby.
18
4. The Closing. The time and date of closing and delivery of the documents required to be delivered to the
Placement Agent pursuant to Sections 5 and 7 hereof shall be at 10:00 A.M., New
York time, on May 7, 2009 (the “Closing Date”) at the office of Xxxxxx Xxxxxxx Xxxxxx & Xxxxx, LLP,
000 Xxxxx Xxxxxx, Xxxxx 0000, Xxxxxxxxx, Xxxxxxxxx 00000.
5. Further Agreements of the Company. The Company agrees with the Placement Agent and the Purchasers:
(a) To prepare the Prospectus in a form approved by the Placement Agent containing
information previously omitted at the time of effectiveness of the Registration Statement in
reliance on Rules 430A, 430B and 430C of the Rules and Regulations and to file such
Prospectus pursuant to Rule 424(b) of the Rules and Regulations not later than the second
(2nd) business day following the execution and delivery of this Agreement or, if
applicable, such earlier time as may be required by Rule 430A of the Rules and Regulations;
to notify the Placement Agent immediately of the Company’s intention to file or prepare any
supplement or amendment to any Registration Statement or to the Prospectus and to make no
amendment or supplement to the Registration Statement, the General Disclosure Package or to
the Prospectus to which the Placement Agent shall reasonably object by notice to the Company
after a reasonable period to review; to advise the Placement Agent, promptly after it
receives notice thereof, of the time when any amendment to any Registration Statement has
been filed or becomes effective or any supplement to the General Disclosure Package or the
Prospectus or any amended Prospectus has been filed and to furnish the Placement Agent copies
thereof; to file promptly all material required to be filed by the Company with the
Commission pursuant to Rule 433(d) or 163(b)(2) of the Rules and Regulations, as the case may
be; to file promptly all reports and any definitive proxy or information statements required
to be filed by the Company with the Commission pursuant to Section 13(a), 13(c), 14 or 15(d)
of the Exchange Act subsequent to the date of the Prospectus and for so long as the delivery
of a prospectus (or in lieu thereof, the notice referred to in Rule 173(a) of the Rules and
Regulations) is required in connection with the offering or sale of the Units; to advise the
Placement Agent, promptly after it receives notice thereof, of the issuance by the Commission
of any stop order or of any order preventing or suspending the use of any Preliminary
Prospectus, any Issuer Free Writing Prospectus or the Prospectus, of the suspension of the
qualification of the Units for offering or sale in any jurisdiction, of the initiation or
threatening of any proceeding for any such purpose, or of any request by the Commission for
the amending or supplementing of the Registration Statement, the General Disclosure Package
or the Prospectus or for additional information; and, in the event of the issuance of any
stop order or of any order preventing or suspending the use of any Preliminary Prospectus,
any Issuer Free Writing Prospectus or the Prospectus or suspending any such qualification,
and promptly to use its best efforts to obtain the withdrawal of such order.
(b) The Company represents and agrees that it has not made and, unless it obtains the
prior consent of the Placement Agent, it will not, make any offer relating to the Units that
would constitute a “free writing prospectus” as defined in Rule 405 of the Rules and
Regulations unless the prior written consent of the Placement Agent has been received (each,
a “Permitted Free Writing Prospectus”); provided that the prior written
19
consent of the Placement Agent hereto shall be deemed to have been given in respect of the
Issuer Free Writing Prospectus(es) included in Schedule A hereto. The Company
represents that it has treated and agrees that it will treat each Permitted Free Writing
Prospectus as an Issuer Free Writing Prospectus, comply with the requirements of Rules 164
and 433 of the Rules and Regulations applicable to any Issuer Free Writing Prospectus,
including the requirements relating to timely filing with the Commission, legending and
record keeping and will not take any action that would result in the Placement Agent or the
Company being required to file with the Commission pursuant to Rule 433(d) of the Rules and
Regulations a free writing prospectus prepared by or on behalf of the Placement Agent that
the Placement Agent otherwise would not have been required to file thereunder.
(c) If at any time when a Prospectus relating to the Units is required to be delivered
under the Securities Act, any event occurs or condition exists as a result of which the
Prospectus, as then amended or supplemented, would include any untrue statement of a material
fact or omit to state a material fact necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading, or the Registration
Statement, as then amended or supplemented, would include any untrue statement of a material
fact or omit to state a material fact necessary to make the statements therein not
misleading, or if for any other reason it is necessary at any time to amend or supplement any
Registration Statement or the Prospectus to comply with the Securities Act or the Exchange
Act, the Company will promptly notify the Placement Agent, and upon the Placement Agent’s
request, the Company will promptly prepare and file with the Commission, at the Company’s
expense, an amendment to the Registration Statement or an amendment or supplement to the
Prospectus that corrects such statement or omission or effects such compliance and will
deliver to the Placement Agent, without charge, such number of copies thereof as the
Placement Agent may reasonably request. The Company consents to the use of the Prospectus or
any amendment or supplement thereto by the Placement Agent.
(d) If the General Disclosure Package is being used to solicit offers to buy the Units
at a time when the Prospectus is not yet available to prospective purchasers and any event
shall occur as a result of which, in the judgment of the Company or in the reasonable opinion
of the Placement Agent, it becomes necessary to amend or supplement the General Disclosure
Package in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading, or to make the statements therein not conflict with the
information contained or incorporated by reference in the Registration Statement then on file
and not superseded or modified, or if it is necessary at any time to amend or supplement the
General Disclosure Package to comply with any law, the Company promptly will either (i)
prepare, file with the Commission (if required) and furnish to the Placement Agent and any
dealers an appropriate amendment or supplement to the General Disclosure Package or (ii)
prepare and file with the Commission an appropriate filing under the Exchange Act which shall
be incorporated by reference in the General Disclosure Package so that the General Disclosure
Package as so amended or supplemented will not, in the light of the circumstances under which
they were made, be misleading or conflict with the
20
Registration Statement then on file, or so that the General Disclosure Package will comply
with law.
(e) If at any time following issuance of an Issuer Free Writing Prospectus there
occurred or occurs an event or development as a result of which such Issuer Free Writing
Prospectus conflicted or will conflict with the information contained in the Registration
Statement, Pricing Prospectus or Prospectus, including any document incorporated by reference
therein and any prospectus supplement deemed to be a part thereof and not superseded or
modified or included or would include an untrue statement of a material fact or omitted or
would omit to state a material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which they were made,
not misleading, the Company has promptly notified or will promptly notify the Placement Agent
so that any use of the Issuer Free Writing Prospectus may cease until it is amended or
supplemented and has promptly amended or will promptly amend or supplement, at its own
expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue
statement or omission. The foregoing sentence does not apply to statements in or omissions
from any Issuer Free Writing Prospectus in reliance upon, and in conformity with, written
information furnished to the Company by the Placement Agent specifically for inclusion
therein, which information the parties hereto agree is limited to the Placement Agent’s
Information (as defined in Section 17).
(f) To the extent not available on the Commission’s XXXXX or IDEA system, or any
successor thereto, to furnish promptly to the Placement Agent and to counsel for the
Placement Agent a signed copy of the Registration Statement as originally filed with the
Commission, and of each amendment thereto filed with the Commission, including all consents
and exhibits filed therewith.
(g) To the extent not available on the Commission’s XXXXX or IDEA system, or any
successor thereto, to deliver promptly to the Placement Agent in New York City such number of
the following documents as the Placement Agent shall reasonably request: (i) conformed
copies of the Registration Statement as originally filed with the Commission (in each case
excluding exhibits), (ii) each Preliminary Prospectus (if any), (iii) any Issuer Free Writing
Prospectus, (iv) the Prospectus (the delivery of the documents referred to in clauses (i),
(ii), (iii) and (iv) of this paragraph (g) to be made not later than 10:00 A.M., New
York time, on the business day following the execution and delivery of this Agreement), (v)
conformed copies of any amendment to the Registration Statement (excluding exhibits), (vi)
any amendment or supplement to the General Disclosure Package or the Prospectus (the delivery
of the documents referred to in clauses (v) and (vi) of this paragraph (g) to be made
not later than 10:00 A.M., New York City time, on the business day following the date of such
amendment or supplement) and (vii) any document incorporated by reference in the General
Disclosure Package or the Prospectus (excluding exhibits thereto) (the delivery of the
documents referred to in clause (vi) of this paragraph (g) to be made not later than
10:00 A.M., New York City time, on the business day following the date of such document).
21
(h) To make generally available to its shareholders as soon as practicable, but in any
event not later than eighteen (18) months after the effective date of each Registration
Statement (as defined in Rule 158(c) of the Rules and Regulations), an earnings statement of
the Company and its subsidiaries (which need not be audited) complying with Section 11(a) of
the Securities Act and the Rules and Regulations (including, at the option of the Company,
Rule 158); and to furnish to its shareholders after the end of each fiscal year an annual
report (including a balance sheet and statements of income, shareholders’ equity and cash
flows of the Company and its consolidated subsidiaries certified by independent public
accountants) and after each of the first three fiscal quarters of each fiscal year (beginning
with the first fiscal quarter after the effective date of such Registration Statement),
consolidated summary financial information of the Company and its subsidiaries for such
quarter in reasonable detail.
(i) To take promptly from time to time such actions as the Placement Agent may
reasonably request to qualify the Units for offering and sale under the securities or Blue
Sky laws of such jurisdictions (domestic or foreign) as the Placement Agent may designate and
to continue such qualifications in effect, and to comply with such laws, for so long as
required to permit the offer and sale of the Securities in such jurisdictions; provided that
the Company and its subsidiaries shall not be obligated to qualify as foreign corporations in
any jurisdiction in which they are not so qualified or to file a general consent to service
of process in any jurisdiction.
(j) To the extent not available on the Commission’s XXXXX or IDEA system, or any
successor thereto, upon request, during the period of five (5) years from the date hereof, to
deliver to the Placement Agent, (i) copies of all reports or other communications furnished
to shareholders, promptly upon their dissemination, and (ii) as promptly after filing, copies
of any reports and financial statements furnished or filed with the Commission or any
national securities exchange or automatic quotation system on which the Common Stock is
listed or quoted.
(k) That the Company will not, for a period of ninety (90) days from the date of the
Prospectus, (the “Lock-Up Period”) without the prior written consent of the Placement Agent,
directly or indirectly offer, sell, assign, transfer, pledge, contract to sell, or otherwise
dispose of, any shares of Common Stock or any securities convertible into or exercisable or
exchangeable for Common Stock, other than the Company’s sale of the Units (including the
Shares and the Warrants included in the Units) hereunder and the issuance of restricted
Common Stock or options to acquire Common Stock pursuant to the Company’s employee benefit
plans, qualified stock option plans or other employee compensation plans as such plans are in
existence on the date hereof and described in the Prospectus and the issuance of Common Stock
pursuant to the valid exercises of options, warrants or rights or vesting of restricted stock
units outstanding on the date hereof. The Company will cause each executive officer and
director listed in Schedule B to furnish to the Placement Agent, prior to the Closing
Date, a letter, substantially in the form of Exhibit C hereto. The Company also
agrees that during such period, the Company will not file any registration statement,
preliminary prospectus or prospectus, or any amendment or supplement thereto, under the
Securities Act for any such transaction or which registers, or offers for sale, Common Stock
or any securities convertible into or
22
exercisable or exchangeable for Common Stock, except for a registration statement on Form S-8
relating to employee benefit plans. The Company hereby agrees that (i) if it issues an
earnings release or material news, or if a material event relating to the Company occurs,
during the last seventeen (17) days of the Lock-Up Period, or (ii) if prior to the expiration
of the Lock-Up Period, the Company announces that it will release earnings results during the
sixteen (16)-day period beginning on the last day of the Lock-Up Period, the restrictions
imposed by this paragraph (k) or the letter shall continue to apply until the
expiration of the eighteen (18)-day period beginning on the issuance of the earnings release
or the occurrence of the material news or material event.
(l) To supply the Placement Agent with copies of all correspondence to and from, and all
documents issued to and by, the Commission in connection with the registration of the Units
under the Securities Act or the Registration Statement, any Preliminary Prospectus or the
Prospectus, or any amendment or supplement thereto or document incorporated by reference
therein.
(m) Prior to the Closing Date, to furnish to the Placement Agent, as soon as they have
been prepared, copies of any unaudited interim consolidated financial statements of the
Company for any periods subsequent to the periods covered by the financial statements
appearing in the Registration Statement and the Prospectus.
(n) Prior to the Closing Date, not to issue any press release or other publicly
disseminated communication directly or indirectly or hold any press conference with respect
to the Company, its condition, financial or otherwise, or earnings, business affairs or
business prospects (except for routine oral marketing communications in the ordinary course
of business and consistent with the past practices of the Company and of which the Placement
Agent is notified), without the prior written consent of the Placement Agent, unless in the
judgment of the Company and its counsel, and after notification to the Placement Agent, such
press release or communication is required by law or applicable stock exchange rules.
(o) Until the Placement Agent shall have notified the Company of the completion of the
offering of the Units, that the Company will not, and will cause its affiliated purchasers
(as defined in Regulation M under the Exchange Act) not to, either alone or with one or more
other persons, bid for or purchase, for any account in which it or any of its affiliated
purchasers has a beneficial interest, any Units, or attempt to induce any person to purchase
any Units; and not to, and to cause its affiliated purchasers not to, make bids or purchase
for the purpose of creating actual, or apparent, active trading in or of raising the price of
the Units.
(p) Not to take any action prior to the Closing Date which would require the Prospectus
to be amended or supplemented pursuant to Section 5.
(q) To at all times comply with all applicable provisions of the Xxxxxxxx-Xxxxx Act in
effect from time to time.
23
(r) To apply the net proceeds from the sale of the Units as set forth in the
Registration Statement, the General Disclosure Package and the Prospectus under the heading
“Use of Proceeds.”
(s) To use its best efforts to list, effect and maintain, subject to notice of issuance,
the Common Stock on the Nasdaq GM.
(t) To use its best efforts to do and perform all things required to be done or
performed under this Agreement by the Company prior to the Closing Date and to satisfy all
conditions precedent to the delivery of the Units.
6. Payment of Expenses. The Company agrees to pay, or reimburse if paid by the Placement Agent, whether or not the
transactions contemplated hereby are consummated or this Agreement is terminated: (a) the costs
incident to the authorization, issuance, sale, preparation and delivery of the Units to the
Purchasers and any taxes payable in that connection; (b) the costs incident to the Registration of
the Units under the Securities Act; (c) the costs incident to the preparation, printing and
distribution of the Registration Statement, the Base Prospectus, any Preliminary Prospectus, any
Issuer Free Writing Prospectus, the General Disclosure Package, the Prospectus, any amendments,
supplements and exhibits thereto or any document incorporated by reference therein and the costs of
printing, reproducing and distributing any transaction document by mail, telex or other means of
communications; (d) if applicable, the fees and expenses (including related fees and expenses of
counsel for the Placement Agent) incurred in connection with securing any required review by FINRA
of the terms of the sale of the Units and any filings made with FINRA; (e) any applicable listing,
quotation or other fees; (f) the fees and expenses (including related fees and expenses of counsel
to the Placement Agent) of qualifying the Units under the securities laws of the several
jurisdictions as provided in Section 5(i) and of preparing, printing and distributing
wrappers, Blue Sky Memoranda and Legal Investment Surveys; (g) the cost of preparing and printing
stock certificates; (h) all fees and expenses of the registrar and transfer agent of the Units; (i)
the fees, disbursements and expenses of counsel to the Placement Agent, not to exceed $125,000 and
(j) all other costs and expenses incident to the offering of the Units or the performance of the
obligations of the Company under this Agreement (including, without limitation, the fees and
expenses of the Company’s counsel and the Company’s independent accountants and the travel and
other expenses incurred by Company personnel in connection with any “road show” including, without
limitation, any expenses advanced by the Placement Agent on the Company’s behalf (which will be
promptly reimbursed)).
7. Conditions to the Obligations of the Placement Agent and the Purchasers, and
the Sale of the Units. The respective obligations of the Placement Agent hereunder and the Purchasers under the
Subscription Agreements, and the Closing of the sale of the Units, are subject to the accuracy,
when made and as of the Applicable Time and on the Closing Date, of the representations and
warranties of the Company contained herein, to the accuracy of the statements of the Company made
in any certificates pursuant to the provisions hereof, to the performance by the Company of its
obligations hereunder, and to each of the following additional terms and conditions:
24
(a) No stop order suspending the effectiveness of the Registration Statement or any part
thereof, preventing or suspending the use of any Base Prospectus, any Preliminary Prospectus,
the Prospectus or any Permitted Free Writing Prospectus or any part thereof shall have been
issued and no proceedings for that purpose or pursuant to Section 8A under the Securities Act
shall have been initiated or threatened by the Commission, and all requests for additional
information on the part of the Commission (to be included or incorporated by reference in the
Registration Statement or the Prospectus or otherwise) shall have been complied with to the
reasonable satisfaction of the Placement Agent, each Issuer Free Writing Prospectus, if any,
and the Prospectus shall have been filed with the Commission within the applicable time
period prescribed for such filing by, and in compliance with, the Rules and Regulations and
in accordance with Section 5(a); and if applicable, FINRA shall have raised no
objection to the fairness and reasonableness of the terms of this Agreement or the
transactions contemplated hereby.
(b) The Placement Agent shall not have discovered and disclosed to the Company on or
prior to the Closing Date that the Registration Statement or any amendment or supplement
thereto contains an untrue statement of a fact which, in the opinion of counsel for the
Placement Agent, is material or omits to state any fact which, in the opinion of such
counsel, is material and is required to be stated therein or is necessary to make the
statements therein not misleading, or that the General Disclosure Package, any Issuer Free
Writing Prospectus or the Prospectus or any amendment or supplement thereto contains an
untrue statement of fact which, in the opinion of such counsel, is material or omits to state
any fact which, in the opinion of such counsel, is material and is necessary in order to make
the statements, in the light of the circumstances in which they were made, not misleading.
(c) All corporate proceedings and other legal matters incident to the authorization,
form and validity of each of this Agreement, the Subscription Agreements, the Units, the
Registration Statement, the General Disclosure Package, each Issuer Free Writing Prospectus,
if any, and the Prospectus and all other legal matters relating to this Agreement and the
transactions contemplated hereby shall be reasonably satisfactory in all material respects to
counsel for the Placement Agent, and the Company shall have furnished to such counsel all
documents and information that they may reasonably request to enable them to pass upon such
matters.
(d) Xxxxxx Xxxxxxx Xxxxxx & Xxxxx, LLP shall have furnished to the Placement Agent such
counsel’s written opinion and negative assurances statement, as counsel to the Company,
addressed to the Placement Agent, dated the Closing Date, in form and substance reasonably
satisfactory to the Placement Agent.
(e) The Placement Agent shall have received from Proskauer Rose LLP, counsel for the
Placement Agent, such opinion or opinions and negative assurances statement, addressed to the
Placement Agent, dated the Closing Date, with respect to such matters as the Placement Agent
may reasonably require, and the Company shall have furnished to such counsel such documents
as they request for enabling them to pass upon such matters.
25
(f) At the time of the execution of this Agreement, the Placement Agent shall have
received from Deloitte & Touche LLP a letter, addressed to the Placement Agent, executed and
dated such date, in form and substance satisfactory to the Placement Agent (i) confirming
that they are an independent registered accounting firm with respect to the Company and its
subsidiaries within the meaning of the Securities Act and the Rules and Regulations and PCAOB
and (ii) stating the conclusions and findings of such firm, of the type ordinarily included
in accountants’ “comfort letters” to underwriters, with respect to the financial statements
and certain financial information contained or incorporated by reference in the Registration
Statement, the General Disclosure Package and the Prospectus.
(g) On the effective date of any post-effective amendment to any Registration Statement
and on the Closing Date, the Placement Agent shall have received a letter (the “Bring-Down
Letter”) from Deloitte & Touche LLP addressed to the Placement Agent and dated the Closing
Date confirming, as of the date of the Bring-Down Letter (or, with respect to matters
involving changes or developments since the respective dates as of which specified financial
information is given in the General Disclosure Package and the Prospectus, as the case may
be, as of a date not more than three (3) business days prior to the date of the Bring-Down
Letter), the conclusions and findings of such firm, of the type ordinarily included in
accountants’ “comfort letters” to underwriters, with respect to the financial information and
other matters covered by its letter delivered to the Placement Agent concurrently with the
execution of this Agreement pursuant to paragraph (f) of this Section 7.
(h) The Company shall have furnished to the Placement Agent a certificate, dated the
Closing Date, of its Chairman of the Board, its President or a Vice President and its chief
financial officer stating that (i) such officers have carefully examined the Registration
Statement, the General Disclosure Package, any Permitted Free Writing Prospectus and the
Prospectus and, in their opinion, the Registration Statement and each amendment thereto, at
the Applicable Time and as of the date of this Agreement and as of the Closing Date did not
include any untrue statement of a material fact and did not omit to state a material fact
required to be stated therein or necessary to make the statements therein not misleading, and
the General Disclosure Package, as of the Applicable Time and as of the Closing Date, any
Permitted Free Writing Prospectus as of its date and as of the Closing Date, the Prospectus
and each amendment or supplement thereto, as of the respective date thereof and as of the
Closing Date, did not include any untrue statement of a material fact and did not omit to
state a material fact necessary in order to make the statements therein, in the light of the
circumstances in which they were made, not misleading, (ii) since the effective date of the
initial Registration Statement, no event has occurred which should have been set forth in a
supplement or amendment to the Registration Statement, the General Disclosure Package or the
Prospectus, (iii) to their knowledge after reasonable investigation, as of the Closing Date,
the representations and warranties of the Company in this Agreement are true and correct in
all material respects (except that any representation and warranty that is qualified as to
materiality shall be true and correct in all respects) and the Company has, in all material
respects, complied with all agreements and satisfied all conditions on its part to be
performed or satisfied hereunder at or prior to the Closing Date, and (iv) there has not
been, subsequent to the
26
date of the most recent audited financial statements included or incorporated by reference in
the General Disclosure Package, any material adverse change in the financial position or
results of operations of the Company and its subsidiaries, or any change or development that,
singularly or in the aggregate, would involve a material adverse change or a prospective
material adverse change, in or affecting the condition (financial or otherwise), results of
operations, business, assets or prospects of the Company and its subsidiaries taken as a
whole, except as set forth in the Prospectus.
(i) Since the date of the latest audited financial statements included in the General
Disclosure Package or incorporated by reference in the General Disclosure Package as of the
date hereof, (i) neither the Company nor any of its subsidiaries shall have sustained any
loss or interference with its business from fire, explosion, flood or other calamity, whether
or not covered by insurance, or from any labor dispute or court or governmental action, order
or decree, otherwise than as set forth in the General Disclosure Package, and (ii) there
shall not have been any change in the capital stock (other than as a result in the ordinary
course of business of the issuance of Common Stock issued pursuant to the exercise of stock
options under the Company’s stock plans, the issuance of Common Stock under the Company’s
stock plans, and the issuance of Common Stock pursuant to employee stock purchase plans) or
long-term debt of the Company nor any of its subsidiaries, or any change, or any development
involving a prospective change, in or affecting the business, general affairs, management,
financial position, stockholders’ equity or results of operations of the Company and its
subsidiaries, otherwise than as set forth in the General Disclosure Package, the effect of
which, in any such case described in clause (i) or (ii) of this paragraph (i), is, in
the judgment of the Placement Agent, so material and adverse as to make it impracticable or
inadvisable to proceed with the sale or delivery of the Units on the terms and in the manner
contemplated in the General Disclosure Package.
(j) No action shall have been taken and no law, statute, rule, regulation or order shall
have been enacted, adopted or issued by any governmental agency or body which would prevent
the issuance or sale of the Units or materially and adversely affect or potentially
materially and adversely affect the business or operations of the Company or its
subsidiaries; and no injunction, restraining order or order of any other nature by any
federal or state court of competent jurisdiction shall have been issued which would prevent
the issuance or sale of the Units or materially and adversely affect or potentially
materially and adversely affect the business or operations of the Company or its
subsidiaries.
(k) Subsequent to the execution and delivery of this Agreement there shall not have
occurred any of the following: (i) trading in securities generally on the New York Stock
Exchange, NasdaqGM or the American Stock Exchange or in the over-the-counter market, or
trading in any securities of the Company on any exchange or in the over-the-counter market,
shall have been suspended or materially limited, or minimum or maximum prices or maximum
range for prices shall have been established on any such exchange or such market by the
Commission, by such exchange or market or by any other regulatory body or governmental
authority having jurisdiction, (ii) a banking moratorium shall have been declared by Federal
or state authorities or a material
27
disruption has occurred in commercial banking or securities settlement or clearance services
in the United States, (iii) the United States shall have become engaged in hostilities, or
the subject of an act of terrorism, or there shall have been an outbreak of or escalation in
hostilities involving the United States, or there shall have been a declaration of a national
emergency or war by the United States or (iv) there shall have occurred such a material
adverse change in general economic, political or financial conditions (or the effect of
international conditions on the financial markets in the United States shall be such) as to
make it, in the judgment of the Placement Agent, impracticable or inadvisable to proceed with
the sale or delivery of the Units on the terms and in the manner contemplated in the General
Disclosure Package and the Prospectus.
(l) The Company shall have filed a Notification Form: Listing of Additional Shares with
the NasdaqGM and shall have received no objection thereto from the NasdaqGM.
(m) The Placement Agent shall have received the written agreements, substantially in the
form of Exhibit C hereto, of the executive officers and directors of the Company
listed in Schedule B to this Agreement.
(n) The Company shall have entered into Subscription Agreements with each of the
Purchasers and such agreements shall be in full force and effect.
(o) If applicable, the Placement Agent shall have received clearance from FINRA as to
the amount of compensation allowable or payable to the Placement Agent as described in the
Pricing Prospectus.
(p) Prior to the Closing Date, the Company shall have furnished to the Placement Agent
such further information, opinions, certificates (including a Secretary’s Certificate),
letters or documents as the Placement Agent shall have reasonably requested.
All opinions, letters, evidence and certificates mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Placement Agent.
8. Indemnification and Contribution.
(a) The Company shall indemnify and hold harmless the Placement Agent, its affiliates
and each of its and their respective directors, officers, members, employees, representatives
and agents (including, without limitation Lazard Frères & Co. LLC, (which will provide
services to the Placement Agent) and its affiliates, and each of its and their respective
directors, officers, members, employees, representatives and agents and each person, if any,
who controls Lazard Frères & Co. LLC within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act) and each person, if any, who controls the Placement Agent
within the meaning of Section 15 of the Securities Act of or Section 20 of the Exchange Act
(collectively, the “Placement Agent Indemnified Parties,” and each a “Placement Agent
Indemnified Party”) against any loss, claim, damage, expense or liability whatsoever (or any
action, investigation or
28
proceeding in respect thereof), joint or several, to which such Placement Agent Indemnified
Party may become subject, under the Securities Act or otherwise, insofar as such loss, claim,
damage, expense, liability, action, investigation or proceeding arises out of or is based
upon (A) any untrue statement or alleged untrue statement of a material fact contained in any
Preliminary Prospectus, any Issuer Free Writing Prospectus, any “issuer information” filed or
required to be filed pursuant to Rule 433(d) of the Rules and Regulations, any Registration
Statement or the Prospectus, or in any amendment or supplement thereto or document
incorporated by reference therein, (B) the omission or alleged omission to state in any
Preliminary Prospectus, any Issuer Free Writing Prospectus, any “issuer information” filed or
required to be filed pursuant to Rule 433(d) of the Rules and Regulations, any Registration
Statement or the Prospectus, or in any amendment or supplement thereto or document
incorporated by reference therein, a material fact required to be stated therein or necessary
to make the statements therein not misleading or (C) any breach of the representations and
warranties of the Company contained herein, or the failure of the Company to perform its
obligations hereunder or pursuant to any law, and shall reimburse the Placement Agent
Indemnified Party promptly upon demand for any legal fees or other expenses reasonably
incurred by that Placement Agent Indemnified Party in connection with investigating, or
preparing to defend, or defending against, or appearing as a third party witness in respect
of, or otherwise incurred in connection with, any such loss, claim, damage, expense,
liability, action, investigation or proceeding, as such fees and expenses are incurred;
provided, however, that the Company shall not be liable in any such case to the extent that
any such loss, claim, damage, expense or liability arises out of or is based upon an untrue
statement or alleged untrue statement in, or omission or alleged omission from any
Preliminary Prospectus, any Registration Statement or the Prospectus, or any such amendment
or supplement thereto, or any Issuer Free Writing Prospectus made in reliance upon and in
conformity with written information furnished to the Company by the Placement Agent
specifically for use therein, which information the parties hereto agree is limited to the
Placement Agent’s Information (as defined in Section 17). This indemnity agreement
is not exclusive and will be in addition to any liability, which the Company might otherwise
have and shall not limit any rights or remedies which may otherwise be available at law or in
equity to each Placement Agent Indemnified Party.
(b) The Placement Agent shall indemnify and hold harmless the Company and its directors,
its officers who signed the Registration Statement and each person, if any, who controls the
Company within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act (collectively, the “Company Indemnified Parties,” and each a “Company Indemnified Party”)
against any loss, claim, damage, expense or liability whatsoever (or any action,
investigation or proceeding in respect thereof), joint or several, to which such Company
Indemnified Party may become subject, under the Securities Act or otherwise, insofar as such
loss, claim, damage, expense, liability, action, investigation or proceeding arises out of or
is based upon (i) any untrue statement or alleged untrue statement of a material fact
contained in any Preliminary Prospectus, any Issuer Free Writing Prospectus, any “issuer
information” filed or required to be filed pursuant to Rule 433(d) of the Rules and
Regulations, any Registration Statement or the Prospectus, or in any amendment or supplement
thereto, or (ii) the omission or alleged omission to state in any Preliminary Prospectus, any
Issuer Free Writing Prospectus, any
29
“issuer information” filed or required to be filed pursuant to Rule 433(d) of the Rules and
Regulations, any Registration Statement or the Prospectus, or in any amendment or supplement
thereto, a material fact required to be stated therein or necessary to make the statements
therein not misleading, but in each case only to the extent that the untrue statement or
alleged untrue statement or omission or alleged omission was made in reliance upon and in
conformity with written information furnished to the Company by the Placement Agent
specifically for use therein, which information the parties hereto agree is limited to the
Placement Agent’s Information as defined in Section 17, and shall reimburse the
Company for any legal or other expenses reasonably incurred by such party in connection with
investigating or preparing to defend or defending against or appearing as third party witness
in connection with any such loss, claim, damage, liability, action, investigation or
proceeding, as such fees and expenses are incurred. This indemnity agreement is not
exclusive and will be in addition to any liability, which the Placement Agent might otherwise
have and shall not limit any rights or remedies which may otherwise be available at low or in
equity to each Company Indemnified Party. Notwithstanding the provisions of this Section
8(b), in no event shall any indemnity by the Placement Agent under this Section
8(b) exceed the total compensation received by the Placement Agent in accordance with
Section 2.5.
(c) Promptly after receipt by an indemnified party under this Section 8 of
notice of the commencement of any action, the indemnified party shall, if a claim in respect
thereof is to be made against an indemnifying party under this Section 8, notify such
indemnifying party in writing of the commencement of that action; provided, however, that the
failure to notify the indemnifying party shall not relieve it from any liability which it may
have under this Section 8 except to the extent it has been materially prejudiced by
such failure; and, provided, further, that the failure to notify an indemnifying party shall
not relieve it from any liability which it may have to an indemnified party otherwise than
under this Section 8. If any such action shall be brought against an indemnified
party, and it shall notify the indemnifying party thereof, the indemnifying party shall be
entitled to participate therein and, to the extent that it wishes, jointly with any other
similarly notified indemnifying party, to assume the defense of such action with counsel
reasonably satisfactory to the indemnified party (which counsel shall not, except with the
written consent of the indemnified party, be counsel to the indemnifying party). After
notice from the indemnifying party to the indemnified party of its election to assume the
defense of such action, except as provided herein, the indemnifying party shall not be liable
to the indemnified party under Section 8 for any legal or other expenses subsequently
incurred by the indemnified party in connection with the defense of such action other than
reasonable costs of investigation; provided, however, that any indemnified party shall have
the right to employ separate counsel in any such action and to participate in the defense of
such action but the fees and expenses of such counsel (other than reasonable costs of
investigation) shall be at the expense of such indemnified party unless (i) the employment
thereof has been specifically authorized in writing by the Company in the case of a claim for
indemnification under Section 8(a) or Section 2.6 or the Placement Agent in
the case of a claim for indemnification under Section 8(b), (ii) such indemnified
party shall have been advised by its counsel that there may be one or more legal defenses
available to it which are different from or additional to those available to the indemnifying
party, or (iii) the
30
indemnifying party has failed to assume the defense of such action and employ counsel
reasonably satisfactory to the indemnified party within a reasonable period of time after
notice of the commencement of the action or the indemnifying party does not diligently defend
the action after assumption of the defense, in which case, if such indemnified party notifies
the indemnifying party in writing that it elects to employ separate counsel at the expense of
the indemnifying party, the indemnifying party shall not have the right to assume the defense
of (or, in the case of a failure to diligently defend the action after assumption of the
defense, to continue to defend) such action on behalf of such indemnified party and the
indemnifying party shall be responsible for legal or other expenses subsequently incurred by
such indemnified party in connection with the defense of such action; provided, however, that
the indemnifying party shall not, in connection with any one such action or separate but
substantially similar or related actions in the same jurisdiction arising out of the same
general allegations or circumstances, be liable for the reasonable fees and expenses of more
than one separate firm of attorneys at any time for all such indemnified parties (in addition
to any local counsel), which firm shall be designated in writing by Placement Agent if the
indemnified parties under this Section 8 consist of any Placement Agent Indemnified
Party or by the Company if the indemnified parties under this Section 8 consist of
any Company Indemnified Parties. Subject to this Section 8(c), the amount payable by
an indemnifying party under Section 8 shall include, but not be limited to, (x)
reasonable legal fees and expenses of counsel to the indemnified party and any other expenses
in investigating, or preparing to defend or defending against, or appearing as a third party
witness in respect of, or otherwise incurred in connection with, any action, investigation,
proceeding or claim, and (y) all amounts paid in settlement of any of the foregoing. No
indemnifying party shall, without the prior written consent of the indemnified parties,
settle or compromise or consent to the entry of judgment with respect to any pending or
threatened action or any claim whatsoever, in respect of which indemnification or
contribution could be sought under this Section 8 (whether or not the indemnified
parties are actual or potential parties thereto), unless such settlement, compromise or
consent (i) includes an unconditional release of each indemnified party in form and substance
reasonably satisfactory to such indemnified party from all liability arising out of such
action or claim and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party. Subject to the
provisions of the following sentence, no indemnifying party shall be liable for settlement of
any pending or threatened action or any claim whatsoever that is effected without its written
consent (which consent shall not be unreasonably withheld or delayed), but if settled with
its written consent, if its consent has been unreasonably withheld or delayed or if there be
a judgment for the plaintiff in any such matter, the indemnifying party agrees to indemnify
and hold harmless any indemnified party from and against any loss or liability by reason of
such settlement or judgment. In addition, if at any time an indemnified party shall have
requested that an indemnifying party reimburse the indemnified party for fees and expenses of
counsel, such indemnifying party agrees that it shall be liable for any settlement of the
nature contemplated herein effected without its written consent if (i) such settlement is
entered into more than forty-five (45) days after receipt by such indemnifying party of the
request for reimbursement, (ii) such indemnifying party shall have received notice of the
terms of such settlement at least thirty (30) days prior to such settlement being entered
into and
31
(iii) such indemnifying party shall not have reimbursed such indemnified party in accordance
with such request prior to the date of such settlement.
(d) If the indemnification provided for in this Section 8 is unavailable or
insufficient to hold harmless an indemnified party under Section 8(a) or Section
8(b), then each indemnifying party shall, in lieu of indemnifying such indemnified party,
contribute to the amount paid, payable or otherwise incurred by such indemnified party as a
result of such loss, claim, damage, expense or liability (or any action, investigation or
proceeding in respect thereof), as incurred, (i) in such proportion as shall be appropriate
to reflect the relative benefits received by the Company on the one hand and the Placement
Agent on the other hand from the offering of the Units, or (ii) if the allocation provided by
clause (i) of this Section 8(d) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) of this Section 8(d) but also the relative fault of the Company on the one hand
and the Placement Agent on the other with respect to the statements, omissions, acts or
failures to act which resulted in such loss, claim, damage, expense or liability (or any
action, investigation or proceeding in respect thereof) as well as any other relevant
equitable considerations. The relative benefits received by the Company on the one hand and
the Placement Agent on the other with respect to such offering shall be deemed to be in the
same proportion as the total net proceeds from the offering of the Units purchased under this
Agreement (before deducting expenses) received by the Company bear to the total Placement Fee
received by the Placement Agent in connection with the Offering, in each case as set forth in
the table on the cover page of the Prospectus. The relative fault of the Company on the one
hand and the Placement Agent on the other shall be determined by reference to, among other
things, whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company on
the one hand or the Placement Agent on the other, the intent of the parties and their
relative knowledge, access to information and opportunity to correct or prevent such untrue
statement, omission, act or failure to act; provided that the parties hereto agree that the
written information furnished to the Company by the Placement Agent for use in any
Preliminary Prospectus, any Registration Statement or the Prospectus, or in any amendment or
supplement thereto, consists solely of the Placement Agent’s Information as defined in
Section 17. The Company and the Placement Agent agree that it would not be just and
equitable if contributions pursuant to this Section 8(d) were to be determined by pro
rata allocation or by any other method of allocation that does not take into account the
equitable considerations referred to herein. The amount paid or payable by an indemnified
party as a result of the loss, claim, damage, expense, liability, action, investigation or
proceeding referred to above in this Section 8(d) shall be deemed to include, for
purposes of this Section 8(d), any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating, preparing to defend or defending
against or appearing as a third party witness in respect of, or otherwise incurred in
connection with, any such loss, claim, damage, expense, liability, action, investigation or
proceeding. Notwithstanding the provisions of this Section 8(d), no Placement Agent
shall be required to contribute any amount in excess of the total compensation received by
such Placement Agent in accordance with Section 2.5 less the amount of any damages
which such Placement Agent has otherwise paid or become liable to pay by reason of any untrue
32
or alleged untrue statement, omission or alleged omission, act or alleged act or failure to
act or alleged failure to act. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any
person who was not guilty of such fraudulent misrepresentation.
9. Termination. The obligations of the Placement Agent and the Purchasers hereunder and under the
Subscription Agreements may be terminated by the Placement Agent, in its absolute discretion by
notice given to the Company prior to delivery of and payment for the Units if, prior to that time,
any of the events described in Sections 7(i), 7(j) or 7(k) have occurred or
if the Purchasers shall decline to purchase the Units for any reason permitted under this Agreement
or the Subscription Agreements.
10. Reimbursement of Placement Agent’s Expenses. Notwithstanding anything to the contrary in this Agreement, if (a) this Agreement shall
have been terminated pursuant to Section 9, (b) the Company shall fail to tender the Units
for delivery to the Purchasers for any reason not permitted under this Agreement, (c) the
Purchasers shall decline to purchase the Units for any reason permitted under this Agreement or (d)
the sale of the Units is not consummated because any condition to the obligations of the Purchasers
or the Placement Agent set forth herein is not satisfied or because of the refusal, inability or
failure on the part of the Company to perform any agreement herein or to satisfy any condition or
to comply with the provisions hereof, then, in addition to the payment of any amounts in accordance
with Section 6, the Company shall reimburse the Placement Agent for the fees and expenses
of the Placement Agent’s counsel and for such other out-of-pocket expenses as shall have been
reasonably incurred by them in connection with this Agreement and the proposed purchase of the
Units, and upon demand the Company shall pay the full amount thereof to the Placement Agent.
11. Absence of Fiduciary Relationship. The Company acknowledges and agrees that:
(a) the Placement Agent’s responsibility to the Company is solely contractual in nature,
the Placement Agent has been retained solely to act as Placement Agent in connection with the
Offering and no fiduciary, advisory or agency relationship between the Company and the
Placement Agent has been created in respect of any of the transactions contemplated by this
Agreement, irrespective of whether the Placement Agent or Lazard Frères & Co. LLC has advised
or is advising the Company on other matters;
(b) the price of the Units set forth in this Agreement was established by the Company
following discussions and arms-length negotiations with the Placement Agent, and the Company
is capable of evaluating and understanding, and understands and accepts, the terms, risks and
conditions of the transactions contemplated by this Agreement;
(c) it has been advised that the Placement Agent and Lazard Frères & Co. LLC and their
affiliates are engaged in a broad range of transactions which may involve interests that
differ from those of the Company and that the Placement Agent has no
33
obligation to disclose such interests and transactions to the Company by virtue of any
fiduciary, advisory or agency relationship; and
(d) it waives, to the fullest extent permitted by law, any claims it may have against
the Placement Agent for breach of fiduciary duty or alleged breach of fiduciary duty and
agrees that the Placement Agent shall have no liability (whether direct or indirect) to the
Company in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty
claim on behalf of or in right of the Company, including stockholders, employees or creditors
of the Company.
12. Successors; Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of and be binding upon the Placement Agent, the
Company, and their respective successors and assigns. This Agreement shall also inure to the
benefit of Lazard Frères & Co. LLC, the Purchasers, and each of their respective successors and
assigns, which shall be third party beneficiaries hereof. Notwithstanding the foregoing, as
provided in the Subscription Agreements, the determination as to whether any condition in
Section 7 hereof shall have been satisfied, and the waiver of any condition in Section
7 hereof, may be made by the Placement Agent in its sole discretion, and any such determination
or waiver shall be binding on each of the Purchasers and shall not require the consent of any
Purchaser. Nothing expressed or mentioned in this Agreement is intended or shall be construed to
give any person, other than the persons mentioned in the preceding sentences, any legal or
equitable right, remedy or claim under or in respect of this Agreement, or any provisions herein
contained, this Agreement and all conditions and provisions hereof being intended to be and being
for the sole and exclusive benefit of such persons and for the benefit of no other person; except
that the representations, warranties, covenants, agreements and indemnities of the Company
contained in this Agreement shall also be for the benefit of the Placement Agent Indemnified
Parties and the indemnities of the Placement Agent shall be for the benefit of the Company
Indemnified Parties. It is understood that the Placement Agent’s responsibility to the Company is
solely contractual in nature and the Placement Agent does not owe the Company, or any other party,
any fiduciary duty as a result of this Agreement.
13. Survival of Indemnities, Representations, Warranties, etc. The respective indemnities, covenants, agreements, representations, warranties and other
statements of the Company and the Placement Agent, as set forth in this Agreement or made by them
respectively, pursuant to this Agreement, shall remain in full force and effect, regardless of any
investigation made by or on behalf of the Placement Agent, the Company, the Purchasers or any
person controlling any of them and shall survive delivery of and payment for the Units.
Notwithstanding any termination of this Agreement, including without limitation any termination
pursuant to Sections 9 or 10, the indemnity and contribution agreements contained
in Section 8 and the covenants, representations, warranties set forth in this Agreement
shall not terminate and shall remain in full force and effect at all times.
14. Notices. All statements, requests, notices and agreements hereunder shall be in writing, and:
34
(a) if to the Placement Agent, shall be delivered or sent by mail, telex, facsimile
transmission or email to Lazard Capital Markets LLC, Attention: General Counsel, Fax:
000-000-0000; and
(b) if to the Company, shall be delivered or sent by mail, telex, facsimile transmission
or email to Capstone Turbine Corporation, 00000 Xxxxxxxx Xxxxxx, Xxxxxxxxxx, Xxxxxxxxxx
00000, Attention: Chief Financial Officer, facsimile: (000) 000-0000, with a copy, which
shall not constitute notice, to: Xxxxxx Xxxxxxx Xxxxxx & Xxxxx, LLP, 000 Xxxxx Xxxxxx, Xxxxx
0000, Xxxxxxxxx, Xxxxxxxxx 00000, Attention: X. Xxxxx Xxxx, Esq., Facsimile: (000) 000-0000.
provided, however, that any notice to the Placement Agent pursuant to Section 8 shall be
delivered or sent by mail, telex or facsimile transmission to the Placement Agent at its address
set forth in its acceptance telex to the Placement Agent, which address will be supplied to any
other party hereto by the Placement Agent upon request. Any such statements, requests, notices or
agreements shall take effect at the time of receipt thereof, except that any such statement,
request, notice or agreement delivered or sent by email shall take effect at the time of
confirmation of receipt thereof by the recipient thereof.
15. Definition of Certain Terms. For purposes of this Agreement, (a) “business day” means any day on which the New York
Stock Exchange, Inc. is open for trading and (b) “subsidiary” has the meaning set forth in Rule 405
of the Rules and Regulations.
16. Governing Law, Agent for Service and Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State
of New York, including without limitation Section 5-1401 of the New York General Obligations Law.
No legal proceeding may be commenced, prosecuted or continued in any court other than the courts of
the State of New York located in the City and County of New York or in the United States District
Court for the Southern District of New York, which courts shall have jurisdiction over the
adjudication of such matters, and the Company and the Placement Agent each hereby consent to the
jurisdiction of such courts and personal service with respect thereto. The Company and the
Placement Agent each hereby consent to personal jurisdiction, service and venue in any court in
which any legal proceeding arising out of or in any way relating to this Agreement is brought by
any third party against the Company or the Placement Agent. The Company and the Placement Agent
each hereby waive all right to trial by jury in any legal proceeding (whether based upon contract,
tort or otherwise) in any way arising out of or relating to this Agreement. The Company agrees
that a final judgment in any such legal proceeding brought in any such court shall be conclusive
and binding upon the Company and the Placement Agent and may be enforced in any other courts in the
jurisdiction of which the Company is or may be subject, by suit upon such judgment.
17. Placement Agent’s Information. The parties hereto acknowledge and agree that, for all purposes of this Agreement, the
Placement Agent’s Information consists solely of the following information in the Prospectus: (i)
the last paragraph on the front cover page concerning the terms of the offering by the Placement
Agent; and (ii) the statements concerning the Placement Agent contained in the first paragraph
under the heading “Plan of Distribution.”
35
18. Partial Unenforceability. The invalidity or unenforceability of any section, paragraph, clause or provision of this
Agreement shall not affect the validity or enforceability of any other section, paragraph, clause
or provision hereof. If any section, paragraph, clause or provision of this Agreement is for any
reason determined to be invalid or unenforceable, there shall be deemed to be made such minor
changes (and only such minor changes) as are necessary to make it valid and enforceable.
19. General. This Agreement constitutes the entire agreement of the parties to this Agreement and
supersedes all prior written or oral and all contemporaneous oral agreements, understandings and
negotiations with respect to the subject matter hereof. In this Agreement, the masculine, feminine
and neuter genders and the singular and the plural include one another. The section headings in
this Agreement are for the convenience of the parties only and will not affect the construction or
interpretation of this Agreement. This Agreement may be amended or modified, and the observance of
any term of this Agreement may be waived, only by a writing signed by the Company and the Placement
Agent.
20. Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon the same
instrument and such signatures may be delivered by facsimile.
36
If the foregoing is in accordance with your understanding of the agreement between the Company
and the Placement Agent, kindly indicate your acceptance in the space provided for that purpose
below.
Very truly yours, CAPSTONE TURBINE CORPORATION |
||||
By: | ||||
Name: | ||||
Title: | ||||
Accepted as of the date first above written: LAZARD CAPITAL MARKETS LLC |
||||
By: | ||||
Name: | ||||
Title: |
37
SCHEDULE
A
General Use Free Writing Prospectuses
None.
SCHEDULE
B
List of executive officers and directors subject to Section 5
Xxxxxxx Xxxxxxxx
Xxxx Xxxxxxx
Xxxxxx Xxxxxxx
Xxxx Xxxxx
Xxxx Xxxx
Xxxxx Xxxxxxx
Xxxx Xxxxx
Xxxxx Xxx Xxxxxxx
Xxxxxxx Xxxx
Xxx Xxxxxx
Xxxx Xxxxxxxx
Xx Xxxxx
Xxxxx Xxxxxx
Xxxx Xxxxxxx
Xxxxxx Xxxxxxx
Xxxx Xxxxx
Xxxx Xxxx
Xxxxx Xxxxxxx
Xxxx Xxxxx
Xxxxx Xxx Xxxxxxx
Xxxxxxx Xxxx
Xxx Xxxxxx
Xxxx Xxxxxxxx
Xx Xxxxx
Xxxxx Xxxxxx
EXHIBIT A
Form of Subscription Agreement
EXHIBIT B
Form of Warrant
EXHIBIT C
Form of Lock Up Agreement
May [__], 2009
LAZARD CAPITAL MARKETS LLC
00 Xxxxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
00 Xxxxxxxxxxx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Re: | Capstone Turbine Corporation offering of [____] Units |
Dear Sirs:
In order to induce Lazard Capital Markets LLC (“Lazard”) to enter into a certain placement
agent agreement with Capstone Turbine Corporation, a Delaware corporation (the “Company”), with
respect to the offering of units consisting of the Company’s Common Stock, par value $0.001 per
share (“Common Stock”), and warrants to purchase the Common Stock (collectively, with the Common
Stock, the “Units”), the undersigned hereby agrees that for a period (the “lock-up period”) of
ninety (90) days following the date of the final prospectus supplement filed by the Company with
the Securities and Exchange Commission in connection with such public offering, the undersigned
will not, without the prior written consent of Lazard, directly or indirectly, (i) offer, sell,
assign, transfer, pledge, contract to sell, or otherwise dispose of, any shares of Common Stock or
securities convertible into or exercisable or exchangeable for Common Stock (including, without
limitation, shares of Common Stock or any such securities which may be deemed to be beneficially
owned by the undersigned in accordance with the rules and regulations promulgated under the
Securities Act of 1933, as the same may be amended or supplemented from time to time (such shares
or securities, the “Beneficially Owned Shares”)), (ii) enter into any swap, hedge or other
agreement or arrangement that transfers in whole or in part, the economic risk of ownership of any
Beneficially Owned Shares, Common Stock or securities convertible into or exercisable or
exchangeable for Common Stock, or (iii) engage in any short selling of any Beneficially Owned
Shares, Common Stock or securities convertible into or exercisable or exchangeable for Common
Stock.
Notwithstanding the foregoing, nothing contained herein will be deemed to restrict or prohibit
the transfer of Beneficially Owned Shares as a bona fide gift, provided, however, that the donees,
distributees or transferees thereof agree in writing to be bound by the terms hereof.
If (i) the Company issues an earnings release or material news or a material event relating to
the Company occurs during the last seventeen (17) days of the lock-up period, or (ii) prior to the
expiration of the lock-up period, the Company announces that it will release earnings results
during the sixteen (16)-day period beginning on the last day of the lock-up period, the
restrictions imposed by this Agreement shall continue to apply until the expiration of the eighteen
(18)-day period beginning on the issuance of the earnings release or the occurrence of the material
news or material event.
Anything contained herein to the contrary notwithstanding, any person to whom shares of Common
Stock, securities convertible into or exercisable or exchangeable for Common Stock or
Beneficially Owned Shares are transferred from the undersigned shall be bound by the terms of
this Agreement.
In addition, the undersigned hereby waives, from the date hereof through the ninetieth
(90th) day following the date of the Company’s final prospectus, any and all rights, if
any, to request or demand registration pursuant to the Securities Act of 1933, as amended, of any
shares of Common Stock or securities convertible into or exercisable or exchangeable for Common
Stock that are registered in the name of the undersigned or that are Beneficially Owned Shares. In
order to enable the aforesaid covenants to be enforced, the undersigned hereby consents to the
placing of legends and/or stop transfer orders with the transfer agent of the Common Stock with
respect to any shares of Common Stock, securities convertible into or exercisable or exchangeable
for Common Stock or Beneficially Owned Shares.
Name: | ||||
Title: | ||||